Interventional radiology (Higashimatsuyama-shi (Japan)最新文献_第2页

Interventional Radiology in Treating Acute Mesenteric Arterial Occlusion: A Narrative Review. 介入放射治疗急性肠系膜动脉闭塞：叙述回顾。

Interventional radiology (Higashimatsuyama-shi (Japan) Pub Date : 2024-12-13 eCollection Date: 2025-03-28 DOI: 10.22575/interventionalradiology.2024-0018

Koji Sasaki, Takuya Okada, Masato Yamaguchi, Masashi Ozaki, Yutaro Okamoto, Akihiro Umeno, Tomoharu Yamanaka, Keigo Matsushiro, Tomoyuki Gentsu, Eisuke Ueshima, Keitaro Sofue, Takamichi Murakami

{"title":"Interventional Radiology in Treating Acute Mesenteric Arterial Occlusion: A Narrative Review.","authors":"Koji Sasaki, Takuya Okada, Masato Yamaguchi, Masashi Ozaki, Yutaro Okamoto, Akihiro Umeno, Tomoharu Yamanaka, Keigo Matsushiro, Tomoyuki Gentsu, Eisuke Ueshima, Keitaro Sofue, Takamichi Murakami","doi":"10.22575/interventionalradiology.2024-0018","DOIUrl":"10.22575/interventionalradiology.2024-0018","url":null,"abstract":"Acute mesenteric arterial occlusion, resulting from impaired blood flow in the superior mesenteric artery, is classified into embolism and thrombosis; both conditions lead to rapid intestinal ischemia, with a high mortality rate of >30% within 30 days. A multidisciplinary treatment approach, including prompt revascularization, necrotic intestinal tract resection, intensive postoperative care, and recurrence prevention, is crucial for managing acute mesenteric arterial occlusion. Recent meta-analyses have indicated that endovascular treatments result in lower bowel resection and mortality rates than open revascularization. As a minimally invasive treatment option, endovascular therapy can become prevalent in the aging population. Interventional radiologists who provide diagnostic imaging and endovascular procedures must understand the disease and play a central role in the treatment team.","PeriodicalId":73503,"journal":{"name":"Interventional radiology (Higashimatsuyama-shi (Japan)","volume":"10 ","pages":"e20240018"},"PeriodicalIF":0.0,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12078031/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144096060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A Case of Successful Treatment of Gastric Varices Due to Left-sided Portal Hypertension with Multidisciplinary Treatment Including Transportal Coil-assisted Balloon-occluded Retrograde Transvenous Obliteration II and Partial Splenic Embolization. 多学科联合治疗左门静脉高压症胃静脉曲张1例，包括经静脉逆行栓塞和部分脾栓塞。

Interventional radiology (Higashimatsuyama-shi (Japan) Pub Date : 2024-12-13 eCollection Date: 2025-03-28 DOI: 10.22575/interventionalradiology.2023-0025

Yuki Sakai, Akira Yamamoto, Atsushi Jogo, Ryuichi Kita, Hitomi Hirose, Kanami Ikeda, Eisaku Terayama, Masanori Ozaki, Kazuki Murai, Ken Kageyama, Etsuji Sohgawa, Teruhisa Ninoi, Yukio Miki

引用次数: 0

Systemic Therapy Combined with Locoregional Therapy in Intermediate-stage Hepatocellular Carcinoma. 中期肝细胞癌的全身联合局部治疗。

Interventional radiology (Higashimatsuyama-shi (Japan) Pub Date : 2024-12-13 eCollection Date: 2025-03-28 DOI: 10.22575/interventionalradiology.2023-0035

Masatoshi Kudo

{"title":"Systemic Therapy Combined with Locoregional Therapy in Intermediate-stage Hepatocellular Carcinoma.","authors":"Masatoshi Kudo","doi":"10.22575/interventionalradiology.2023-0035","DOIUrl":"10.22575/interventionalradiology.2023-0035","url":null,"abstract":"Recent advances in systemic therapy for hepatocellular carcinoma are remarkable. The treatment goal for advanced hepatocellular carcinoma is to prolong survival, while for intermediate-stage hepatocellular carcinoma, it is to achieve a cancer-free and drug-free status. Patients unsuitable for transarterial chemoembolization may benefit from prior systemic therapy with lenvatinib or atezolizumab plus bevacizumab. The TACTICS-L trial, a prospective phase II trial, demonstrated favorable progression-free and overall survival by lenvatinib-transarterial chemoembolization sequential therapy. The REPLACEMENT trial, a multicenter, prospective, single-arm phase II trial, confirmed combination immunotherapy efficacy with atezolizumab plus bevacizumabin a population exceeding up-to-seven criteria. In a proof-of-concept study, atezolizumab plus bevacizumab plus curative therapy showed a 35% complete response rate and 23% drug-free status in intermediate-stage hepatocellular carcinoma patients with a tumor burden exceeding up-to-seven criteria.","PeriodicalId":73503,"journal":{"name":"Interventional radiology (Higashimatsuyama-shi (Japan)","volume":"10 ","pages":"e20230035"},"PeriodicalIF":0.0,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12078074/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144095968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Transjugular Intrahepatic Portosystemic Shunt Creation in Isolated Persistent Left Superior Vena Cava and Portal Vein Thrombosis. 经颈静脉肝内门静脉系统分流术在孤立持续性左上腔静脉和门静脉血栓形成中的应用。

Interventional radiology (Higashimatsuyama-shi (Japan) Pub Date : 2024-12-13 eCollection Date: 2025-03-28 DOI: 10.22575/interventionalradiology.2024-0002

Sara Rostami, Ryan Dunn, Derek Rubadeux, Ali Kord

{"title":"Transjugular Intrahepatic Portosystemic Shunt Creation in Isolated Persistent Left Superior Vena Cava and Portal Vein Thrombosis.","authors":"Sara Rostami, Ryan Dunn, Derek Rubadeux, Ali Kord","doi":"10.22575/interventionalradiology.2024-0002","DOIUrl":"10.22575/interventionalradiology.2024-0002","url":null,"abstract":"Isolated persistent left superior vena cava is a rare congenital venous anomaly. It imposes technical challenges and increased risks in patients requiring a transjugular intrahepatic portosystemic shunt. The patient was a 67-year-old man with cirrhosis, recurrent large-volume ascites, hepatic hydrothorax, and portal vein thrombosis. The patient had a history of failed transjugular intrahepatic portosystemic shunt creation using a conventional CO2 portal venography technique via a left jugular vein access. The patient underwent successful transjugular intrahepatic portosystemic shunt creation under fluoroscopy and intravascular ultrasound guidance. The patient required transjugular intrahepatic portosystemic shunt revision with mechanical thrombectomy in 2 months. Intravascular ultrasound can provide additional live information to assist transjugular intrahepatic portosystemic shunt creation in patients with complex congenital venous anatomy, including those with isolated persistent left superior vena cava.","PeriodicalId":73503,"journal":{"name":"Interventional radiology (Higashimatsuyama-shi (Japan)","volume":"10 ","pages":"e20240002"},"PeriodicalIF":0.0,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12078028/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144095973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Combining Cutting and Drug-eluting Balloon for Resistant Arteriovenous Fistula Stenosis (CONCERTO)-A Pilot Study. 联合切割和药物洗脱球囊治疗顽固性动静脉瘘狭窄(CONCERTO)-一项试点研究。

Interventional radiology (Higashimatsuyama-shi (Japan) Pub Date : 2024-12-13 eCollection Date: 2025-03-28 DOI: 10.22575/interventionalradiology.2024-0030

Kun Da Zhuang, Mark Wang Qi Wei, Shaun Xavier Chan Ju Min, Apoorva Gogna, Nanda Venkatanarasimha, Ankur Patel, Jasmine Chua Ming Er, Farah Gillan Irani, Sum Leong, Chow Wei Too, Sivanathan Chandramohan, Kiang Hiong Tay, Bien Soo Tan

{"title":"Combining Cutting and Drug-eluting Balloon for Resistant Arteriovenous Fistula Stenosis (CONCERTO)-A Pilot Study.","authors":"Kun Da Zhuang, Mark Wang Qi Wei, Shaun Xavier Chan Ju Min, Apoorva Gogna, Nanda Venkatanarasimha, Ankur Patel, Jasmine Chua Ming Er, Farah Gillan Irani, Sum Leong, Chow Wei Too, Sivanathan Chandramohan, Kiang Hiong Tay, Bien Soo Tan","doi":"10.22575/interventionalradiology.2024-0030","DOIUrl":"10.22575/interventionalradiology.2024-0030","url":null,"abstract":"Purpose: To evaluate the feasibility and preliminary evidence of the efficacy of combined cutting balloon and drug-coated balloon angioplasty for the treatment of arteriovenous fistula stenoses resistant to conventional balloon angioplasty. Material and Methods: From August 2018 to January 2019, 19 patients (mean age = 64.9 ± 8.6 years; males = 63%) with resistant arteriovenous fistula stenosis, defined as >30% residual stenosis after conventional balloon angioplasty, were enrolled into this single-center prospective pilot study. The resistant arteriovenous fistula stenoses were treated with a cutting balloon followed by a drug-coated balloon. The primary outcome measure was 6-month target lesion patency. Results: The degree of residual stenosis after conventional balloon angioplasty was 48.8 ± 11.3%, decreasing to 18.7 ± 10.4% after combined cutting and drug-coated balloon angioplasty. Technical success, defined as < 30% residual stenosis, was achieved in 94.7% (18 of 19 stenoses). The 6-month target lesion patency was 100%, while the 6-month access circuit primary patency was 94.7% (n = 18/19) due to recurrent non-target lesion stenosis. No venous rupture or major complication was encountered. Conclusions: This pilot study provides evidence to support the conduct of a phase 3 randomized clinical trial to prove the superiority of a cutting balloon and drug-coated balloon combination for resistant arteriovenous fistula stenoses.","PeriodicalId":73503,"journal":{"name":"Interventional radiology (Higashimatsuyama-shi (Japan)","volume":"10 ","pages":"e20240030"},"PeriodicalIF":0.0,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12078085/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144095926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Computed Tomography Imaging of Acute Mesenteric Ischemia for Interventional Radiology. 介入放射学中急性肠系膜缺血的计算机断层成像。

Interventional radiology (Higashimatsuyama-shi (Japan) Pub Date : 2024-12-13 eCollection Date: 2025-03-28 DOI: 10.22575/interventionalradiology.2024-0013

Akitoshi Inoue, Shohei Chatani, Ryo Uemura, Yugo Imai, Yuki Tomozawa, Yoko Murakami, Akinaga Sonoda, Neil Roberts, Yoshiyuki Watanabe

{"title":"Computed Tomography Imaging of Acute Mesenteric Ischemia for Interventional Radiology.","authors":"Akitoshi Inoue, Shohei Chatani, Ryo Uemura, Yugo Imai, Yuki Tomozawa, Yoko Murakami, Akinaga Sonoda, Neil Roberts, Yoshiyuki Watanabe","doi":"10.22575/interventionalradiology.2024-0013","DOIUrl":"10.22575/interventionalradiology.2024-0013","url":null,"abstract":"Acute mesenteric ischemia is a life-threatening condition. A comprehensive approach involving a multidisciplinary team to review patient background, clinical history, physical examination, laboratory data, and imaging examination for respective diagnosis of superior mesenteric arterial occlusion, nonocclusive mesenteric ischemia, and superior mesenteric venous occlusion is essential. The most important imaging modality is computed tomography, which is used for diagnosis and for directing therapeutic strategy (e.g., endovascular revascularization, surgical bowel resection, or conservative management). Computed tomography image findings can support triaging of irreversible transmural bowel necrosis compared with reversible ischemic change with reperfusion. In this review article, the computed tomography imaging findings specifically associated with the pathophysiology of superior mesenteric arterial occlusion, nonocclusive mesenteric ischemia, and superior mesenteric venous occlusion are reviewed.","PeriodicalId":73503,"journal":{"name":"Interventional radiology (Higashimatsuyama-shi (Japan)","volume":"10 ","pages":"e20240013"},"PeriodicalIF":0.0,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12078030/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144095928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Endovascular Treatment for Upper Body Central Venous Obstruction. 上半身中心静脉阻塞的血管内治疗。

Interventional radiology (Higashimatsuyama-shi (Japan) Pub Date : 2024-11-22 eCollection Date: 2025-03-28 DOI: 10.22575/interventionalradiology.2023-0043

Shiro Miyayama, Masashi Yamashiro, Rie Ikeda, Akira Yokka, Takeo Fujita, Naoko Sakuragawa

引用次数: 0

Migration of a Stent-graft into the Duodenum after Stent-graft Placement for Proper Hepatic Artery Pseudoaneurysm: A Case Report. 肝动脉假性动脉瘤支架置入术后支架移植物移入十二指肠一例报告。

Interventional radiology (Higashimatsuyama-shi (Japan) Pub Date : 2024-11-22 eCollection Date: 2025-03-28 DOI: 10.22575/interventionalradiology.2024-0020

Kensuke Osaragi, Tomohiro Matsumoto, Rika Yoshimatsu, Junya Ichiki, Marina Osaki, Ryo Hamada, Yoshihiro Noda, Takuji Yamagami

引用次数: 0

Hepatic Portal Venous Gas with Gastric Emphysema after Transcatheter Arterial Embolization for Ruptured Anterior Superior Pancreaticoduodenal Artery Aneurysm. 经导管栓塞治疗胰十二指肠前上动脉瘤破裂后肝门静脉气体伴胃肺气肿。

Interventional radiology (Higashimatsuyama-shi (Japan) Pub Date : 2024-11-22 eCollection Date: 2025-03-28 DOI: 10.22575/interventionalradiology.2024-0007

Masashi Shimohira, Shuji Ikeda, Akiko Narita, Hiroaki Okada, Nozomu Matsunaga, Takahiro Yamamoto, Yuichiro Izumi, Akira Kitagawa, Toyohiro Ota, Kojiro Suzuki

引用次数: 0

Preoperative Image-guided Botulinum Toxin A Injection in Complex Abdominal Wall Hernia Repair. 术前图像引导下A型肉毒毒素注射在复杂腹壁疝修补中的应用。

Interventional radiology (Higashimatsuyama-shi (Japan) Pub Date : 2024-11-22 eCollection Date: 2025-03-28 DOI: 10.22575/interventionalradiology.2023-0044

Jacob Byers, Ali Kord, Megan Turner, Neilendu Kundu, Yasir Khan, Michael Goodman, Seetharam Chadalavada

{"title":"Preoperative Image-guided Botulinum Toxin A Injection in Complex Abdominal Wall Hernia Repair.","authors":"Jacob Byers, Ali Kord, Megan Turner, Neilendu Kundu, Yasir Khan, Michael Goodman, Seetharam Chadalavada","doi":"10.22575/interventionalradiology.2023-0044","DOIUrl":"10.22575/interventionalradiology.2023-0044","url":null,"abstract":"Purpose: This study aimed to examine the effectiveness of preoperative image guided botulinum toxin A injection in achieving fascial closure and reducing recurrence rates after repair of complex incisional abdominal wall hernias. Material and Methods: A total of 32 patients, consisting of 14 males and 18 females, with complex incisional hernias who underwent image guided botulinum toxin A injection at a median 33 [28-38.3] days before surgery were included in this retrospective study. Their mean age was 59.4 ± 11.2 years. Abdominal computed tomography imaging was obtained prior to botulinum toxin A administration to characterize the hernia defects of 26 patients (81.3%, 26/32). The transverse and vertical abdominal wall defects were measured and recorded. Three-dimensional objects of the hernia sac and peritoneal cavity were created based on the delineated borders, and volumes were calculated. The loss of domain was determined using the following formula: where x represents the hernia sac volume and y represents the peritoneal volume. Under ultrasound guidance, the abdominal wall musculature was injected with 300 units of botulinum toxin A across six sites. The fascial closure rate and rate of hernia recurrence were the principal outcomes investigated. Results: Fascial closure was achieved in 29 patients (90.6%, 29/32). Recurrence was observed in two patients (6.3%, 2/32) over an average followup of 2.5 ± 1.5 years (maximum 6.5). Fascial closure was obtained in 12 out of 14 patients with previous hernia repairs (85.7%, 12/14). One botulinum toxin A related complication was observed-a weakened cough that resolved without further treatment. Conclusions: Botulinum toxin A is safe and effective in improving rates of fascial closure and reducing instances of reoccurrence in patients with complex incisional hernias.","PeriodicalId":73503,"journal":{"name":"Interventional radiology (Higashimatsuyama-shi (Japan)","volume":"10 ","pages":"e20230044"},"PeriodicalIF":0.0,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12078083/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144096049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0